Phathom Pharmaceuticals Upgraded by Barclays to Overweight With $18 Target.
Share this article
Corporate
Score 35
Bullish
Phathom Pharmaceuticals Upgraded by Barclays to Overweight With $18 Target
Mar 27, 2026 15:07 UTC
PTHM, XLV, IEX
Short term
Related Articles
Score 45
Micron Stock Rebounds After Analyst Downplays Google Memory Breakthrough Concerns
Mar 27, 17:24
Score 85
Bearish
Microsoft Is Down 24% This Year While Spending $30B a Quarter on AI
Mar 27, 17:15
Score 35
Bullish
Multiple Analysts Bullish on Wingstop Inc’s (WING) Prospects
Mar 27, 17:04
Score 35
TD Cowen Satisfied With Chipotle Mexican Grill’s (CMG) Progress
Mar 27, 17:04
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.